Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Announces Quarterly Dividend of $0.25

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) declared a quarterly dividend on Thursday, October 24th,RTT News reports. Investors of record on Monday, November 18th will be given a dividend of 0.25 per share by the pharmacy operator on Thursday, December 12th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.79%. The ex-dividend date is Monday, November 18th.

Walgreens Boots Alliance has increased its dividend by an average of 1.3% per year over the last three years. Walgreens Boots Alliance has a payout ratio of 63.7% indicating that its dividend is sufficiently covered by earnings. Analysts expect Walgreens Boots Alliance to earn $1.48 per share next year, which means the company should continue to be able to cover its $1.00 annual dividend with an expected future payout ratio of 67.6%.

Walgreens Boots Alliance Trading Down 3.7 %

NASDAQ:WBA opened at $8.48 on Friday. The firm has a fifty day simple moving average of $9.19 and a two-hundred day simple moving average of $11.90. Walgreens Boots Alliance has a 12 month low of $8.22 and a 12 month high of $27.05. The stock has a market capitalization of $7.33 billion, a price-to-earnings ratio of -0.85, a PEG ratio of 1.15 and a beta of 0.69. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, beating the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The company had revenue of $37.50 billion during the quarter, compared to the consensus estimate of $35.75 billion. During the same period last year, the business posted $0.67 EPS. The firm’s revenue for the quarter was up 5.9% compared to the same quarter last year. Analysts expect that Walgreens Boots Alliance will post 1.53 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

WBA has been the topic of a number of research reports. UBS Group upped their target price on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research report on Thursday, October 17th. TD Cowen dropped their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, October 22nd. JPMorgan Chase & Co. decreased their target price on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research report on Friday, August 30th. Morgan Stanley lowered their target price on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a report on Friday, October 11th. Finally, Jefferies Financial Group cut their price target on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, October 23rd. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $12.88.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.